CCIC Annual Meeting 2026 |
October 21-22, 2026 | Delta Hotels Toronto, 75 Lower Simcoe St, Toronto, ON
Dear colleagues,
Registration and abstract submission are now open for the CCIC Annual Meeting 2026.
The meeting will take place October 21–22, 2026 at the Delta Hotels Toronto in downtown Toronto, Ontario. This year’s program will bring together leading researchers, clinicians, trainees, and industry partners to discuss advances in cancer immunotherapy and translational immunology research.
The CCIC meeting will be held back-to-back with the UHN Collaborative Centre for Immunology to Immunotherapy (Ci2i) Symposium on October 23, 2026 at the same venue, providing an additional opportunity for scientific exchange in immunology and immunotherapy across immune-mediated diseases, including autoimmunity, transplantation, and infection.
Keynote Speakers
• Miriam Merad (Mount Sinai School of Medicine)
• Arlene Sharpe (Harvard Medical School)
Featured Speakers
• Arielle Elkrief (Institut du cancer de Montréal)
• Daniel Schramek (Lunenfeld-Tanenbaum Research Institute)
• Christian Hinrichs (Rutgers Cancer Institute)
• Nikhil Joshi (Yale School of Medicine)
• Sam Saibil (Princess Margaret Cancer Centre)
• Sheila Singh (McMaster University)
• André Veillette (IRCM Montréal)
Early Career Investigators
• Stephanie Gaglione (Gladstone Institutes)
• Michael St. Paul (Princess Margaret Cancer Centre)
• Chi Yan (University of Manitoba)
We encourage trainees and early-career investigators to submit abstracts. Selected abstracts will be considered for oral presentations.
For registration, abstract submission, and additional meeting information, please visit: https://event.fourwaves.com/ccic-ci2i-2026/
We look forward to welcoming you to Toronto this October.
On behalf of the CCIC Program Committee,
Michele Ardolino, Naoto Hirano, Kathy McCoy, Brad Nelson, Pam Ohashi
Dear colleagues,
Registration and abstract submission are now open for the CCIC Annual Meeting 2026.
The meeting will take place October 21–22, 2026 at the Delta Hotels Toronto in downtown Toronto, Ontario. This year’s program will bring together leading researchers, clinicians, trainees, and industry partners to discuss advances in cancer immunotherapy and translational immunology research.
The CCIC meeting will be held back-to-back with the UHN Collaborative Centre for Immunology to Immunotherapy (Ci2i) Symposium on October 23, 2026 at the same venue, providing an additional opportunity for scientific exchange in immunology and immunotherapy across immune-mediated diseases, including autoimmunity, transplantation, and infection.
Keynote Speakers
• Miriam Merad (Mount Sinai School of Medicine)
• Arlene Sharpe (Harvard Medical School)
Featured Speakers
• Arielle Elkrief (Institut du cancer de Montréal)
• Daniel Schramek (Lunenfeld-Tanenbaum Research Institute)
• Christian Hinrichs (Rutgers Cancer Institute)
• Nikhil Joshi (Yale School of Medicine)
• Sam Saibil (Princess Margaret Cancer Centre)
• Sheila Singh (McMaster University)
• André Veillette (IRCM Montréal)
Early Career Investigators
• Stephanie Gaglione (Gladstone Institutes)
• Michael St. Paul (Princess Margaret Cancer Centre)
• Chi Yan (University of Manitoba)
We encourage trainees and early-career investigators to submit abstracts. Selected abstracts will be considered for oral presentations.
For registration, abstract submission, and additional meeting information, please visit: https://event.fourwaves.com/ccic-ci2i-2026/
We look forward to welcoming you to Toronto this October.
On behalf of the CCIC Program Committee,
Michele Ardolino, Naoto Hirano, Kathy McCoy, Brad Nelson, Pam Ohashi